← 返回

γδT 细胞在肿瘤免疫治疗中的研究进展

英文原题:Research Progress of γδT Cells in Tumor Immunotherapy.

查看英文原题

Research Progress of γδT Cells in Tumor Immunotherapy.

PubMed 2024/01/01(内容时间) Cancer Control Q2 · IF 3.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

γδT细胞是一种特殊的固有免疫淋巴细胞,不受主要组织相容性复合体(MHC)限制。γδT细胞主要存在于人表皮和黏膜上皮中,可分泌多种细胞因子和趋化因子参与免疫调节,并对癌细胞产生有效的细胞毒反应。

探讨γδT细胞在肿瘤免疫治疗中的作用,了解其抗肿瘤机制,并探索与其他治疗方式的协同效应。该疗法有望成为肿瘤治疗的重要手段。研究设计:本综述对现有文献进行了全面分析,重点关注γδT细胞在多种肿瘤类型中的疗效。

阐明了γδT细胞识别肿瘤抗原并杀伤肿瘤的机制。总结了基于γδT细胞的肿瘤免疫治疗及其在临床实践中的应用。

γδT细胞在肿瘤免疫治疗中显示出良好的潜力,但治疗效果因肿瘤类型而异,部分患者反应不佳。该疾病的治疗仍存在一些挑战,如扩增方案不规范和患者反应不同,表明现有治疗方法尚不完善。未来的研究应着重完善γδT细胞扩增方案,深入了解其抗肿瘤机制,并探索与其他治疗方式的协同作用。这种多方面的研究将推动γδT细胞在肿瘤免疫治疗领域的发展。γδT细胞是不受主要组织相容性复合体(MHC)限制的固有淋巴细胞。这种细胞可以分泌多种物质,这些物质能够对癌细胞产生有效的杀伤作用。γδT细胞是人类上皮内淋巴细胞和黏膜上皮内淋巴细胞(IEL)的主要组成部分之一。由γ链和δ链组成的γδT细胞在抗感染中发挥重要作用。近年来,大量研究证实γδT细胞在消化系统、泌尿系统、血液系统、生殖系统、呼吸系统等系统肿瘤中表现出良好的抗肿瘤作用。因此,基于γδT细胞的细胞免疫治疗是肿瘤免疫治疗的有力补充。本综述将重点关注γδT细胞对肿瘤抗原的识别、杀伤肿瘤的机制、基于γδT细胞的肿瘤免疫治疗及其在临床实践中的应用。

展开英文摘要原文

Background: γδT cells are special innate lymphoid cells, which are not restricted by major histocompatibility complex (MHC). γδT cells mainly exist in human epidermis and mucosal epithelium. They can secrete a variety of cytokines and chemokines involved in immune regulation, and produce effective cytotoxic responses to cancer cells. Purpose: To investigate the role of γδT cells in tumor immunotherapy, to understand its anti-tumor mechanism, and to explore the synergistic effect with other treatment modalities. This therapy is expected to become an important means of cancer treatment. Research Design: In this review presents a comprehensive analysis of the existing literature, focusing on the efficacy of γδT cells in a variety of tumor types. Results: The mechanism of γδT cells recognizing tumor antigens and killing tumor was clarified. The tumor immunotherapy based on γδT cells and its application in clinical practice were summarized. Conclusions: γδT cells have shown promising potential in tumor immunotherapy, but the therapeutic effect varies according to the type of tumor, and some patients have poor response.

There are still some challenges in the treatment of this disease, such as non-standard expansion regimens and different responses of patients, indicating that the existing treatment methods are not complete. Future research should focus on perfecting γδT cell expansion protocols, gaining a deeper understanding of its anti-tumor mechanisms, and exploring synergies with other treatment modalities. This multifaceted study will promote the development of γδT cells in the field of cancer immunotherapy. γδT cells are innate lymphocytes that are not restricted by the major histocompatibility complex (MHC).

This cell can secrete a number of substances, these substances can produce effective killing effect on cancer cells. γδT cells are one of the major components of human intraepithelial lymphocytes and mucosal intraepithelial lymphocytes (IEL).

γδT cells, which are composed of γ and δ chains, play an important role in anti-infection. In recent years, a large number of studies have confirmed that γδT cells have shown good anti-tumor effects in tumors of the digestive system, urinary system, blood system, reproductive system, respiratory system and other systems.

Therefore, γδT cell-based cellular immunotherapy is a powerful supplement to tumor immunotherapy. This review will focus on the recognition of tumor antigens by γδT cells, the mechanism of tumor killing, the tumor immunotherapy based on γδT cells and its application in clinical practice.

论文信息

作者
Li Y、Mo XP、Yao H、Xiong QX
单位
Department of Clinical Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, China.China
文献类型
综述
期刊
Cancer control : journal of the Moffitt Cancer Center2024 Jan-Dec
原文标识
PubMed 39348473 · DOI 10.1177/10732748241284863